Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Bristol Myers Squibb Company has been riding the waves on Zacks.com's trending list, but not all is smooth sailing. Over the ...

The Cigna Group recently disclosed its second quarter 2025 results, boasting a revenue of US$67.18 billion, yet a net income ...

Genetic testing company Natera (NASDAQ:NTRA). will be announcing earnings results this Thursday after market hours. Here’s ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

DelveInsight's Vitiligo Market Insights report includes a comprehensive understanding of current treatment practices, vitiligo emerging ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

LONG BEACH, Calif. -- Depletion of a payment assistance program has translated into worse vision outcomes for older patients ...

The market for chronic obstructive pulmonary disease treatment devices is projected to witness substantial growth, fueled by ...

In July, spending on TV ads for prescription drugs reached a low not seen since this time last year. | In July, spending on TV ads for prescription drugs reached a low not seen since this time last ...

The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing approach.

Oral upadacitinib may be a promising treatment option for patients with atopic dermatitis-type chronic hand eczema that is ...